Home - Products - Others - Other Targets - 15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

CAS No. 420781-85-7

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one( —— )

Catalog No. M32555 CAS No. 420781-85-7

The fruit body of Ganoderma lucidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 664 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    15,26-Dihydroxylanosta-7,9(11),24-trien-3-one
  • Note
    Research use only, not for human use.
  • Brief Description
    The fruit body of Ganoderma lucidum.
  • Description
    The fruit body of Ganoderma lucidum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420781-85-7
  • Formula Weight
    454.7
  • Molecular Formula
    C30H46O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-trans-Caffeoy-L-do...

    cyt-PTPε inhibitor 1 is a potent cytosolic protein tyrosine phosphatase epsilon (cyt-PTPε) inhibitor, which binds to the catalytic domain of cyt-PTPε and blocks c-Src activation Chemical), and has anti-bone breaking activity.

  • Fmoc-PEG12-NHS ester

    Fmoc-PEG12-NHS ester is a PEG-based PROTAC linker that can be used to synthesize PROTACs.

  • IGF-I (24-41) TFA (1...

    IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth Factor I (IGF-I).